Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Arcutis Biotherapeutics
Arcutis Biotherapeutics
(ARQT)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Zoryve
Roflumilast
2022-07-29
2023-2037
Chronic obstructive pulmonary disease
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Roflumilast
memory disorders
,
alzheimer disease
,
healthy volunteers/patients
,
type 2 diabetes mellitus
,
atopic dermatitis
,
eczema
,
dermatitis
,
diabetes mellitus
,
non-alcoholic fatty liver disease
,
inflammation
,
psoriasis
,
asthma
,
respiratory signs and symptoms
,
chronic obstructive pulmonary disease
,
obstructive lung diseases
,
lung diseases
,
respiratory tract diseases
,
respiration disorders
,
disease progression
Aspartame
lymphoma
,
conjunctivitis
,
allergic rhinitis
,
rhinitis
,
allergic conjunctivitis
,
liver neoplasms
,
atopic dermatitis
,
dermatitis
,
neoplasm metastasis
,
healthy volunteers/patients
,
neoplasms
,
prostatic neoplasms
,
vomiting
,
nausea
,
infections
,
esophageal neoplasms
,
postoperative nausea and vomiting
,
brain neoplasms
,
second primary neoplasms
,
treatment-resistant depressive disorder
,
esophageal squamous cell carcinoma
,
renal cell carcinoma
,
experimental liver cirrhosis
,
chronic obstructive pulmonary disease
,
nasopharyngeal carcinoma
,
nasopharyngeal neoplasms
,
recurrence
,
melanoma
,
colorectal neoplasms
,
pancreatic ductal carcinoma
,
biliary tract neoplasms
,
non-muscle invasive bladder neoplasms
,
non-small-cell lung carcinoma
,
hiv infections
,
carcinoma
,
lung neoplasms
,
ovarian neoplasms
,
uterine cervical neoplasms
,
triple negative breast neoplasms
,
breast neoplasms
,
condylomata acuminata
,
hepatocellular carcinoma
,
hiv-2
,
immunologic deficiency syndromes
,
hiv-1
,
antibiotic prophylaxis
,
hepatitis b
,
chronic hepatitis b
,
ovarian epithelial carcinoma
,
coronary disease
,
coronary artery disease
,
myocardial ischemia
,
heart diseases
,
fibrosis
,
lung diseases
,
cystic fibrosis
,
pulmonary hypertension
,
pulmonary arterial hypertension
,
endometrial neoplasms
,
fallopian tube neoplasms
,
urinary bladder neoplasms
,
acquired immunodeficiency syndrome
,
asthma
,
chronic hepatitis c
,
hepatitis
,
hepatitis a
,
hepatitis c
,
hiv
,
neuromuscular blockade
,
hematologic neoplasms
,
hematopoietic stem cell transplantation
,
pneumonia
,
pseudomonas infections
,
pseudomonas aeruginosa
,
gram-negative bacterial infections
,
bacteremia
,
chronic kidney failure
,
kidney diseases
,
chronic hepatitis
,
intestinal diseases
,
hypertension
,
non-hodgkin lymphoma
,
infertility
,
schizophrenia
,
traumatic brain injuries
,
brain concussion
,
brain injuries
,
post-concussion syndrome
,
papillomavirus infections
,
uterine cervical dysplasia
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use